Skip to content

Ethinamate

Drug profile

Also known as: 1-Ethinylcyclohexyl carbamate, 1-Ethynylcyclohexanol carbamate, 1-Ethynylcyclohexyl carbamate, valamin, valmid, valmidate, volamin

OfmFDA approved

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Ethinamate is an ofm drug catalogued in DrugCentral. Recorded indications include Insomnia.

  • Approval status: ofm.
  • Indications: Insomnia.
  • Molecular formula: C9H13NO2; molecular weight 167.21 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

  • Insomnia

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
—FDA—DISTA

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Ethinamate is on its molecule page.

Molecular formulaC9H13NO2
Molecular weight167.21 g/mol
CAS number126-52-3
InChIKeyGXRZIMHKGDIBEW-UHFFFAOYSA-N
PubChem CID3284
NC(=O)OC1(CCCCC1)C#C

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Ethinamate used for?

DrugCentral lists the following indications for Ethinamate: Insomnia.

What is the chemical formula of Ethinamate?

Ethinamate has the molecular formula C9H13NO2 and a molecular weight of 167.21 g/mol.

Browse: all drugs starting with E · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

StatusOFM
First approval—
AgencyFDA
Targets0
Indications1
FormulaC9H13NO2
DrugCentral ID1081
Interactive profile